TradingView
RocketTickers
8 Nov 2019 pukul 17.06

Affimed Announces FDA Clearance of IND to Commence First-in-Huma Pembelian

NASDAQ:AFMD1D
Affimed N.V.NASDAQ

Deskripsi

⋅
AFMD: Affimed N.V.
2019-11-07 16:01:00
Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers
Beyond Technical Analysis
Lebih lanjut